Spanish consensus on infantile haemangioma
Baselga Torres E (1), Bernabéu Wittel J (2), van Esso Arbolave DL (3), Febrer Bosch MI (4), Carrasco Sanz A (5), de Lucas Laguna R (6), Del Pozo Losada J (7), Hernández Martín Á (8), Jiménez Montañés L (9), López Gutiérrez JC (10), Martín-Santiago A (11), Redondo Bellón P (12), Ruíz-Canela Cáceres J (13), Torrelo Fernández A (8), Vera Casaño A (14), Vicente Villa MA (15).
Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences.
The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement.
This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient.
The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients.